Cephalexin therapy of lower respiratory tract, soft tissue and bone infections.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002506:Cephalexin / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D003875:Drug Eruptions / Q000209:etiology; D004886:Erysipelas / Q000188:drug therapy*; D005260:Female; D006193:Haemophilus influenzae; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010019:Osteomyelitis / Q000188:drug therapy*; D011014:Pneumonia / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae; D014839:Vomiting / Q000139:chemically induced; D014946:Wound Infection / Q000188:drug therapy*
D002506:Cephalexin